XML 37 R16.htm IDEA: XBRL DOCUMENT
v3.24.1

Shareholders’ Equity | 12 Months Ended
--- | ---
Dec. 31, 2023
Shareholders’ Equity [Abstract] |
SHAREHOLDERS’ EQUITY | Note 9:- Shareholders’ equity
| a. | In connection with the Merger, the Company adopted its restated articles, pursuant to which the Company’s authorized capital consisted of 130,000,000 Ordinary Shares, with a par value of NIS 0.000216 per share and the Company effected a 1:46.25783 stock split.
| b. | During June 2023, the Company raised $23,000 with Special Situations Funds, pursuant to which the Company issued a total of 11,794,873 Ordinary Shares with a purchase price of $1.95 per share. Existing investors, including two affiliates of Arbe’s directors also participated in this offering. The aggregate net proceeds received by the Company from the offering were $22,496 net of issuance costs.
| c. | Share option and RSU’s:
During 2016, the Company adopted the 2016 Share Incentive Plan (the “2016 Plan”) which provides the Company with the ability to grant its employees, directors and service providers options to purchase Ordinary Shares of the Company, at a purchase price as determined by the Board of Directors at the date of grant. Pursuant to the 2016 Plan, 3,384,454 Ordinary Shares were reserved for issuance. Each option granted under the Plan expires no later than seven years from the date of grant or 60 days after termination of engagement. The vesting period of the share options is generally four years. In August 2021, the Board of the Company approved and in September 2021 the shareholders approved, the Arbe Robotics Ltd. 2021 Equity Incentive Plan (the “2021 Plan”) which became effective on October 7, 2021. The 2021 Plan covers (a) 4,079,427 ordinary shares plus (b) and without the need to further amend the Plan on January 1 of each calendar year beginning on January 1, 2022 and ending on and including January 1, 2031, a number of Shares equal to the lesser of: (i) 5% of the total number of ordinary shares outstanding on December 31 of the immediately preceding calendar year, and (ii) an amount determined by the Board, if so determined prior to the January 1 of the calendar year in which the increase will occur. Upon the adoption of the 2021 Plan, the Company will no longer grant any awards under the 2016 Plan, although previously granted options under the 2016 Plan will remain outstanding and governed by the 2016 Plan and awards available for grant under the 2016 Plan which had not been issued or which expired unexercised may be issued pursuant to the 2021 Plan. The vesting period of the awards is generally four years. Generally, under the terms of the Plans, unless determined otherwise, 25% of an award granted becomes exercisable on the first anniversary of the date of grant and 6.25% becomes exercisable once every quarter during the subsequent three years. Share option and RSU’s plans: A summary of the stock option activity under the Company’s equity plans during the years ended December 31, 2023, 2022 and 2021 is as follows:
|  | Outstanding share options |  |  | Weighted-average exercise price ($) |  |  | Weighted average remaining contractual life (years) |  |  | Aggregate intrinsic value ($ in thousands) |
Options: |  |  |  |  |  |  |  |  |  |  |  |
Outstanding as of December 31, 2020 |  |  | 3,768,034 |  |  |  | 0.767 |  |  |  | 4.626 |  |  |  | 119,146 |
Granted |  |  | 1,966,916 |  |  |  | 7.250 |  |  |  |  |  |  |  |  |
Forfeited |  |  | (117,863 | ) |  |  | 0.972 |  |  |  |  |  |  |  |  |
Exercised |  |  | (155,750 | ) |  |  | 0.602 |  |  |  |  |  |  |  |  |
Outstanding as of December 31, 2021 |  |  | 5,461,337 |  |  |  | 3.102 |  |  |  | 5.363 |  |  |  | 16,713,971 |
Granted |  |  | 1,630,142 |  |  |  | 6.833 |  |  |  |  |  |  |  |  |
Forfeited |  |  | (468,814 | ) |  |  | 5.557 |  |  |  |  |  |  |  |  |
Exercised |  |  | (570,451 | ) |  |  | 0.482 |  |  |  |  |  |  |  |  |
Outstanding as of December 31, 2022 |  |  | 6,052,214 |  |  |  | 4.166 |  |  |  | 5.570 |  |  |  | 7,761,705 |
Granted |  |  | 430,874 |  |  |  | 2.728 |  |  |  |  |  |  |  |  |
Forfeited |  |  | (351,671 | ) |  |  | 7.767 |  |  |  |  |  |  |  |  |
Exercised |  |  | (1,074,162 | ) |  |  | 0.654 |  |  |  |  |  |  |  |  |
Outstanding as of December 31, 2023 |  |  | 5,057,255 |  |  |  | 4.543 |  |  |  | 5.662 |  |  |  | 2,352,517 |
Exercisable as of December 31, 2023 |  |  | 3,210,191 |  |  |  | 3.643 |  |  |  | 4.403 |  |  |  | 2,277,303 |
Options available for future grants |  |  | 611,246 |  |  |  |  |  |  |  |  |  |  |  |  |
A summary of the Company’s RSUs activity during the years ended December 31, 2023, 2022 and 2021 is as follows:
|  | Numbers of RSUs |
RSUs: |  |  |
Outstanding as of January 1, 2021 |  |  | - |
Granted |  |  | 1,968,794 |
Forfeited |  |  | - |
Vested |  |  | - |
Outstanding as of December 31, 2021 |  |  | 1,968,794 |
Granted |  |  | 1,619,898 |
Forfeited |  |  | (417,025 | )
Vested |  |  | (573,583 | )
Outstanding as of December 31, 2022 |  |  | 2,598,084 |
Granted |  |  | 2,908,983 |
Forfeited |  |  | (370,067 | )
Vested |  |  | (895,170 | )
Outstanding as of December 31, 2023 |  |  | 4,241,830 |
Fair value factors: The following table sets forth the parameters used in computation of the options compensation to employees and service providers:
|  | Year ended December 31 |
|  | 2023 |  |  | 2022 |  |  | 2021 |
Expected term, in years |  |  | 5.82 |  |  |  | 4.41-6.11 |  |  |  | 4.61-6.11 |
Expected volatility |  |  | 47%-51.75% |  |  |  | 47%-48% |  |  |  | 42%-46% |
Risk-free interest rate |  |  | 4.15%-4.55% |  |  |  | 1.74%-3.96% |  |  |  | 0.49%-1.28% |
Expected dividend yield |  |  | 0% |  |  |  | 0% |  |  |  | 0% |
Fair value: Prior to the Merger, which resulted in the Company becoming a public entity, in determining the fair value for share options granted, the board of directors considered the fair value of the ordinary shares as of each grant date. The fair value of the ordinary shares underlying the share options was determined by the board of directors at each award grant date based upon a variety of factors, including the results obtained from independent third-party valuations, the Company’s financial position and historical financial performance, the status of technological developments within the Company’s products, the composition and ability of the current management team, an evaluation or benchmark of the Company’s competition, the current business climate in the marketplace, the illiquid nature of the ordinary shares, arm’s length sales of the Company’s capital stock, the effect of the rights and preferences of the Company’s preferred shareholders, and the prospects of a liquidity event, among others. Subsequent to the Company becoming a public entity, the fair value of the Ordinary Shares is the market price of the Ordinary Shares on the date of grant. Expected volatility: As the Company was privately owned until October 2021, there is not sufficient historical volatility for the expected term of the stock options. Therefore, the Company uses an average historical share price volatility based on an analysis of reported data for a peer group of comparable publicly traded companies which were selected based upon industry similarities. Expected term (years): Expected term represents the period that the Company’s option grants are expected to be outstanding. There is not sufficient historical share exercise data to calculate the expected term of the stock options. Therefore, the Company elected to utilize the simplified method to value option grants. Under this approach, the weighted-average expected life is presumed to be the average of the shortest vesting term and the contractual term of the option. Risk-free interest rate: The Company determined the risk-free interest rate by using a weighted-average equivalent to the expected term based on the U.S. Treasury yield curve in effect as of the date of grant. Expected dividend yield: The Company does not anticipate paying any dividends in the foreseeable future. Thus, the Company used 0% as its expected dividend yield. The following table presents stock-based compensation expense to employees included in the Company’s consolidated statements of operations:
|  | Year ended December 31, |
|  | 2023 |  |  | 2022 |  |  | 2021 |
Research and development |  | $ | 8,721 |  |  | $ | 5,726 |  |  | $ | 1,518 |
Sales and marketing |  |  | 2,229 |  |  |  | 1,403 |  |  |  | 217 |
General and administrative |  |  | 1,786 |  |  |  | 1,537 |  |  |  | 419 |
Cost of revenues |  |  | 276 |  |  |  | 127 |  |  |  | 57 |
Total stock-based compensation expense |  | $ | 13,012 |  |  | $ | 8,793 |  |  | $ | 2,211 |
Share based compensation expenses are not deductible for income tax purposes, and therefore the Company did not recognize any tax benefits related to the share-based compensation for the years ended December 31, 2023, 2022 and 2021. The Company adopted ASU 2018-07 and accordingly measured at the grant dates of each of the above stock-based compensation issued to service providers their fair value using Black and Scholes model, which requires inputs such as exercise price, estimated ordinary share price, expected dividend yield, estimated ordinary share price volatility and risk-free interest rate. During 2023, 2022 and 2021, the Company recognized the total fair value of the stock-based compensation of development related service providers in the amounts of $629, $354 and $115, respectively.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration